A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Condition:   Opioid Use Disorder Interventions:   Drug: ASP8062;   Drug: Placebo ASP8062;   Drug: buprenorphine/naloxone Sponsor:   Astellas Pharma Global Development, Inc. Recruiting

Source: ClinicalTrials.gov - June 25, 2020 Category: Research Source Type: clinical trials